Reactions Weekly

, Volume 1658, Issue 1, pp 372–372 | Cite as

Pembrolizumab

Facial diplegia, Guillain-Barre syndrome and autoimmune hepatitis: case report
Case report
  • 25 Downloads

Reference

  1. Yost M, et al. Facial diplegia and autoimmune hepatitis after pembrolizumab therapy. Neurology 88 (Suppl. 16): abstr. P6.138, 18 Apr 2017. Available from: URL: http://www.neurology.org/content/88/16_Supplement/P6.138 [abstract] - USA

Copyright information

© Springer International Publishing AG 2017

Personalised recommendations